Kim Eun Young, Byon Woo Seok, Lee Kwan Ho, Yun Ji-Sup, Park Yong Lai, Park Chan Heun, Youn In Young, Choi Seon Hyeong, Choi Yoon Jung, Kook Shin Ho, Do Sung-Im
Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-Gu, Seoul, 03181, Republic of Korea.
Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-Gu, Seoul, 03181, Republic of Korea.
World J Surg. 2018 Feb;42(2):582-589. doi: 10.1007/s00268-017-4171-8.
The aim of this study was to determine the feasibility of image-guided marker-clip placement in axillary lymph nodes (ALNs) for breast cancer upon initial presentation and to assess the reliability of this method with sentinel lymph node biopsy (SLNB) for axillary restaging after neoadjuvant chemotherapy (NAC).
Between June 2015 and August 2016, a marker clip was placed at a clinically positive ALN under ultrasonography (US) guidance before initiation of NAC in 20 patients. Preoperative localization of marker-clipped LNs was performed, and the localized LNs were removed by SLNB. We compared the postoperative results of the marker-clipped LNs, SLNs and ALNs.
Image-guided marker-clip placements and localization of marker-clipped LNs were performed successfully in 20 patients. A total of 24 marker clips were inserted, and 23 marker-clipped LNs were successfully retrieved during surgery (identification rate, 23/24, 95.8%). In the 11 patients with pathologically confirmed metastatic marker-clipped LNs, four became negative after NAC, and seven maintained metastatic residues on the marker-clipped LNs. Three of the seven patients had metastatic residues on the ALNs, and two of the three patients also had negative SLNs. Marker-clipped nodes accurately predicted the axillary nodal status in these two patients compared with SLNs alone.
Image-guided marker-clip placement on positive ALNs before NAC and removal with SLNB is technically feasible. This technique can improve the accuracy of the residual disease evaluation on the axilla, especially in patients with negative SLNB results, and can identify candidates for limited axillary surgery after NAC.
本研究的目的是确定在乳腺癌初次就诊时在超声引导下将标记夹放置于腋窝淋巴结(ALN)中的可行性,并评估该方法联合前哨淋巴结活检(SLNB)用于新辅助化疗(NAC)后腋窝再分期的可靠性。
2015年6月至2016年8月期间,在20例患者NAC开始前,于超声(US)引导下将标记夹放置于临床阳性的ALN处。对标记夹夹闭的淋巴结进行术前定位,并通过SLNB切除定位的淋巴结。我们比较了标记夹夹闭的淋巴结、前哨淋巴结和腋窝淋巴结的术后结果。
20例患者成功进行了超声引导下标记夹放置及标记夹夹闭淋巴结的定位。共插入24个标记夹,手术中成功取出23个标记夹夹闭的淋巴结(识别率为23/24,95.8%)。在11例病理证实标记夹夹闭的淋巴结有转移的患者中,4例在NAC后转阴,7例标记夹夹闭的淋巴结上仍有转移残留。7例患者中有3例腋窝淋巴结有转移残留,其中3例患者中有2例前哨淋巴结为阴性。与单独的前哨淋巴结相比,标记夹夹闭的淋巴结在这2例患者中准确预测了腋窝淋巴结状态。
NAC前在阳性ALN上进行超声引导下标记夹放置并通过SLNB切除在技术上是可行的。该技术可提高腋窝残留病灶评估的准确性,尤其是在前哨淋巴结活检结果为阴性的患者中,并可识别NAC后适合进行有限腋窝手术的患者。